Search for Clinical Trials

A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive…
  • Cancer - All
  • Cancer - Bladder
  • Urology
GLOFIT: A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
NRG-BN013: Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain MetastasesThis phase…
  • Cancer - All
  • Cancer - Brain
  • Cancer - Breast
  • Cancer - Colon/Rectal
  • Cancer - Kidney/Renal
  • Cancer - Lung
  • Cancer - Metastatic
ROADS Trial: A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (…
  • Brain/Spinal Cord/Nervous System
  • Cancer - All
  • Cancer - Brain
  • Neurology
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who…
  • Cancer - All
  • Cancer - Cervical
  • Obstetrics and Gynecology
A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsThe purpose of this platform study is to evaluate the safety,…
  • Cancer - All
  • Cancer - Colon/Rectal
  • Digestive System
A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in…
  • Cancer - All
  • Cancer - Colon/Rectal
  • Digestive System
S2207: Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients With…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
S1937: A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of…
  • Cancer - All
  • Cancer - Bladder
  • Urology
Back to topback-to-top